Amanda A. Gosman

Amanda A. Gosman

Auto-generated profile, based on publicly available information

Amanda A. Gosman

Department of Surgery, Division of Plastic Surgery, University of California San Diego, La Jolla, CA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2022 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
JCJiwon S. Crowley
Jiwon S. Crowley
MSMax L. B.S. Silverstein
Max L. B.S. Silverstein
MRMeera Reghunathan
Meera Reghunathan
AGAmanda A. Gosman
Amanda A. Gosman
Background: Depression is a leading cause of disability worldwide. Preliminary evidence suggests that glabellar onabotulinumtoxinA injections improve depression scores with few side effects compared to current first-line antidepressant medications. The authors’ review reports on these studies, hypothesizing that glabellar onabotulinumtoxinA injections can be an alternative safe and effective treatment for depression. Methods: A systematic review and meta-analysis of the relevant literature was performed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The PubMed, Cochrane Library, Embase, and Scopus databases were searched in August of 2020 using the keywords [“botox” OR “botulinum”] AND [“mood” OR “depression”] for articles published between 1980 and 2020. Prospective studies and randomized controlled trials on the use of glabellar onabotulinumtoxinA injections for the primary purpose of treating depression were considered. The primary endpoint for the meta-analysis was the mean difference in primary depression scores after treatment, along with a second endpoint of the standardized mean difference in depression scores among treated patients including all nine studies. Results: Of the 499 reviewed articles, nine studies were included that reported improvement in mean depression scores from baseline. All five randomized controlled trials reported an improvement in mean depression scores at 6 weeks after treatment, with a weighted average change of −8.39 points (p < 0.0001). The aggregate standardized mean difference from baseline to the primary endpoint across all nine prospective studies was −1.61 SD (p < 0.0001). Conclusion: Meta-analysis and systematic review of the included studies provide support for an antidepressant effect of glabellar onabotulinumtoxinA injections.

1 May 2021 in Journal of Surgical Education
Verified
Journal Article
Closed access
MRMeera Reghunathan
Meera Reghunathan
IMIshan Mehta
Ishan Mehta
AGAmanda A. Gosman
Amanda A. Gosman

1 November 2021 in Journal of Surgical Education
Verified
Journal Article
Closed access
GDGreta L. Davis
Greta L. Davis
RDRiley A. Dean
Riley A. Dean
CRChristopher M. Reid
Christopher M. Reid
AGAmanda A. Gosman
Amanda A. Gosman

3 February 2021 in Annals of Plastic Surgery
Verified
Journal Article
Closed access
JCJiwon Sarah Crowley
Jiwon Sarah Crowley
TFTzyynong L. Friesen
Tzyynong L. Friesen
RGRodney A. Md Gabriel
Rodney A. Md Gabriel
SHSun Hsieh
Sun Hsieh
AWAmanda Ma Wacenske
Amanda Ma Wacenske
AGAmanda A. Gosman
Amanda A. Gosman
Purpose: The timing and management of patients with cleft palates have been controversial. Early soft palate closure at the time of cleft lip repair followed by hard palate closure at a second stage has been hypothesized to improve speech and audiology outcomes. This study compares cleft palate patients who have undergone single-stage versus 2-stage cleft palate repairs and the outcomes on speech and hearing. Methods: A retrospective chart review identified patients with diagnosis of cleft lip with complete cleft palate who underwent either single or 2-stage repair from 2006 to 2012. Data collected included age at each surgery, necessity of further speech surgery for velopharyngeal insufficiency, frequency of tympanostomy tube placement, presence of hearing loss, and speech assessment data graded per the validated Americleft speech scale. Results: A total of 84 patients were identified and subdivided into groups of single-stage and 2-stage repair. The mean age at the time of single-stage palate repair was 13.3 months. For the 2-stage group, the mean ages were 4.2 and 11.8 months for the soft palate and hard palate repairs, respectively. Comparing the single-stage versus 2-stage palate repairs, there was no significant difference in all speech parameters including hypernasality, hyponasality, nasal air emission, articulation, expressive language, receptive language, speech intelligibility, and speech acceptability for both unilateral and bilateral cleft lip/palate patients. Two-stage repair was associated with increased number of tympanostomy tube placement compared with single-stage repair (relative risk, 1.74; P = 0.009), and the first set of tubes was performed at a statistically significantly younger age, 4.5 months in the 2-stage repair compared with 16.9 months in the single-stage (P = 0.012) with 87.5% performed with first stage of repair. However, there was no difference in the types, degrees of hearing loss, or the presence of at least mild conductive hearing loss at latest follow-up audiograms between the groups. Conclusions: There was no significant benefit with respect to speech or hearing outcomes between single-stage and 2-stage cleft palate repairs. This advocates for surgeon and family preference in the timing of cleft palate repair.

7 January 2021 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
GKGeorge N. Kamel
George N. Kamel
RMRyan M. BS McKee
Ryan M. BS McKee
KCKristine Bs Carbulido
Kristine Bs Carbulido
RMRishi Bs Modi
Rishi Bs Modi
CBCaitlyn Bs Belza
Caitlyn Bs Belza
AGAmanda A. Gosman
Amanda A. Gosman
Introduction: The craniofacial asymmetry seen in unilateral lambdoid craniosynostosis may not be effectively treated by posterior cranial vault remodeling, endoscopic suturectomy, and helmet therapy, or suturectomy and distraction osteogenesis alone due to limitations in soft-tissue envelope expansion and relapse of the deformity. The authors report a series of unilateral lambdoid craniosynostosis patients treated with a posterior rotational cranial-flap technique using internal distraction osteogenesis. Methods: Posterior cranial vault reconstruction combined with internal distraction was used, aided by preoperative virtual surgical planning. An in situ posterior rotational flap osteotomy was utilized to maximize dural preservation. Primary outcome measures included age-adjusted volume change and age-adjusted percent volume change per mm distraction. Distraction characteristics and perioperative characteristics were also assessed. Results: A total of 5 patients were identified. Mean predistraction intracranial volume was 1087.5 cc (SD = 202.3 cc) and mean postdistraction included intracranial volume was 1266.1cc (SD = 131.8cc). Mean age-adjusted percent included intracranial volume change was 14.1% (SD = 9.6%), and mean percent intracranial volume change per mm distraction was 0.43%/mm distraction (SD = 0.37%/mm distraction). One patient developed a distractor site infection postoperatively that was treated successfully with oral antibiotics. All patients had a Whitaker score of 1 at one year follow up. Conclusions: Posterior cranial vault remodeling using osteogenesis and a rotational cranial flap technique with dural preservation can be effectively used to maximize bone flap viability and limit postoperative relapse in patients with unilateral lambdoid craniosynostosis. Long term analysis as well as comparison to open techniques will need to be interrogated.

1 August 2023 in Plastic and Reconstructive Surgery - Global Open
Verified
Journal Article
Open access
AAArya Asghari
Arya Asghari
MOMadeline J. Ba O’connor
Madeline J. Ba O’connor
PAPhilopatir Bs Attalla
Philopatir Bs Attalla
EEEmily Ma Ewing
Emily Ma Ewing
AGArin Md Greene
Arin Md Greene
AGAmanda Gosman
Amanda Gosman
Background: Innovation is an essential aspect of plastic and reconstructive surgery (PRS), whether it involves improving current processes or implementing radical change that disrupts the status quo. Collaborating and sharing innovations help advance the field of PRS as a whole. Methods: An anonymous survey was administered to members of the American Association of Plastic Surgeons on their opinions of the top five innovations in PRS of the last 100 years. Results: A list of 69 unique innovations were compiled; the top five innovations overall were microsurgery, myocutaneous flaps, craniofacial surgery, negative pressure wound therapy, and organ transplantation. This list was reviewed by the American Association of Plastic Surgeons Technology Committee, and expanded to 100 unique innovations. Conclusions: We discuss why the above innovations were essential to the development of PRS, as well as the unique factors that can make a new product or procedure into something that remodels the field of PRS.